Article
In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep‐2 cell line
13 Oct 2008
Abstract excerpt
BACKGROUND: Mounting evidence suggests that most tumors consist of a heterogeneous population of cells with a subset population that has the exclusive tumorigenic ability. They are called cancer stem cells (CSCs). CSCs can self-renew to generate additional CSCs and also differentiate to generate phenotypically diverse cancer cells with limited proliferative potential. They have been identified in a variety of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
